Sunshine Biopharma, Inc.
1177 Avenue of the Americas, 5th Floor
New York , NY 10036
February 9, 2024
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Re: | Sunshine Biopharma, Inc. | |
Registration Statement on Form S-1 | ||
File No. 333-276817 |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Sunshine Biopharma, Inc. hereby respectfully requests acceleration of the effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 4:30 p.m. Eastern Time, February 12, 2024, or as soon as practicable thereafter.
Very truly yours, | ||
Sunshine Biopharma, Inc. | ||
By: | /s/ Dr. Steve N. Slilaty | |
Dr. Steve N. Slilaty Chief Executive Officer |